{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:31:18Z","timestamp":1795059078312,"version":"4.10.2"},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Scleromyxedema (SM) is a rare skin disorder related to monoclonal gammopathy. High dose intravenous immunoglobulins (HDIVIg) are usually used as a frontline therapy with initial efficacy. However, some patients evolve with relapse, refractory state or severe extra\u2010cutaneous complications such as dermato\u2010neuro syndrome (DNS) or cardiac involvement.<\/jats:p><jats:p>The objective of the study is to evaluate the use of anti\u2010plasma cell treatment in these patients in order to obtain a deep and durable dermatological and haematological response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We report here eight patients treated with HDIVIg together with anti\u2010plasma cell therapy including: lenalidomide and dexamethasone (<jats:italic>n<\/jats:italic>\u2009=\u20095); bortezomib, cyclophosphamide and dexamethasone (<jats:italic>n<\/jats:italic>\u2009=\u20091); daratumumab, lenalidomide and dexamethasone (<jats:italic>n<\/jats:italic>\u2009=\u20092).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Combination of HDIVIg with a treatment targeting the monoclonal component led to a high level of haematological remission and drastically improved skin response with an acceptable safety profile in all patients. Moreover, HDIVIg was reduced and stopped in 4 of the 7 patients who achieved complete remission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The association of lenalidomide and dexamethasone with HDIVIg could improve the treatment of relapsed or severe SM.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.20257","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T13:27:39Z","timestamp":1722432459000},"page":"1011-1016","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Plasma cell\u2010directed therapies induce profound clinical and durable responses in patients with severe or relapsed\/refractory scleromyxedema"],"prefix":"10.1111","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3816-1825","authenticated-orcid":false,"given":"F.","family":"Theves","sequence":"first","affiliation":[{"name":"Immuno Hematology Unit Saint Louis Hospital, APHP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lahuna","sequence":"additional","affiliation":[{"name":"Immuno Hematology Unit Saint Louis Hospital, APHP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5951-1831","authenticated-orcid":false,"given":"T.","family":"Mah\u00e9vas","sequence":"additional","affiliation":[{"name":"Dermatology Department Saint Louis Hospital  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Harel","sequence":"additional","affiliation":[{"name":"Immuno Hematology Unit Saint Louis Hospital, APHP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Royer","sequence":"additional","affiliation":[{"name":"Immuno Hematology Unit Saint Louis Hospital, APHP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lemiale","sequence":"additional","affiliation":[{"name":"Intensive Care Unit Saint Louis Hospital  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brignier","sequence":"additional","affiliation":[{"name":"Apheresis Unit Saint Louis Hospital, APHP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Parquet","sequence":"additional","affiliation":[{"name":"Apheresis Unit Saint Louis Hospital, APHP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5286-9689","authenticated-orcid":false,"given":"M.","family":"Jachiet","sequence":"additional","affiliation":[{"name":"Dermatology Department Saint Louis Hospital  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4993-2461","authenticated-orcid":false,"given":"J.\u2010D.","family":"Bouaziz","sequence":"additional","affiliation":[{"name":"Dermatology Department Saint Louis Hospital  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Elessa","sequence":"additional","affiliation":[{"name":"Immuno Hematology Unit Saint Louis Hospital, APHP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Arnulf","sequence":"additional","affiliation":[{"name":"Immuno Hematology Unit Saint Louis Hospital, APHP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6734-413X","authenticated-orcid":false,"given":"A.","family":"Talbot","sequence":"additional","affiliation":[{"name":"Immuno Hematology Unit Saint Louis Hospital, APHP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.111630"},{"issue":"14","key":"e_1_2_11_3_1","first-page":"1101","article-title":"Plasma cell\u2013directed therapies in monoclonal gammopathy\u2013associated scleromyxedema","volume":"135","author":"Mah\u00e9vas T","year":"2020","journal-title":"Blood"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-839480"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14244"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.007"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-237170"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02420.x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02766.x"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4870"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09088.x"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3302"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.028"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90007-1"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404284"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-495929"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26155"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611750"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817249"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.20257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T17:15:37Z","timestamp":1746638137000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.20257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1111\/jdv.20257"],"URL":"https:\/\/doi.org\/10.1111\/jdv.20257","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"2023-11-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}